- Recce Pharmaceuticals (RCE) receives a grant of $50,000 through the Australian Government's Innovations Connections scheme
- The grant is the second of its kind received by RCE and will help assess its lead candidate in the Australian SARS-CoV-2 Antiviral Screening Program
- Led by the CSIRO, stage two of the program will study the efficacy of the therapy over several months, with testing set to start in September
- To date, RCE has received roughly $87,500 plus GST through the scheme
Read the Full Article on The Market Herald here
Recce Pharmaceuticals (ASX:RCE) accepts $50k grant for study with CSIRO
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.5¢ |
Change
0.035(5.38%) |
Mkt cap ! $139.7M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 68.5¢ | 63.0¢ | $218.1K | 325.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3273 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 475 | 1 |
View Market Depth
| Last trade - 16.10pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
66.5¢ |
Change
0.035 ( 9.02 %) |
||||
| Open | High | Low | Volume | ||
| 67.0¢ | 68.5¢ | 65.0¢ | 42123 | ||
| Last updated 15.59pm 25/04/2024 ? | |||||
| RCE (ASX) Chart |